A successive approximation ADC made of a low voltage configurable differential amplifier and low voltage logic circuits which can convert a high voltage analog input to a digital equivalent. The differential amplifier can be configured as either an op amp or a comparator depending upon the mode of operation. An input capacitor C1 is switchably coupled to an electrode selected for voltage sampling. A c1 g0">switched capacitor array C2 is coupled across the differential amplifier input and output. A SAR coupled to the c1 g0">switched capacitor array provides a digital output corresponding to the sampled analog voltage. During a sampling interval and a charge transfer interval, the differential amplifier is configured as an op amp. During the transfer interval, the voltage on the input capacitor multiplied by the ratio C1/C2 is transferred to the c1 g0">switched capacitor array. During an analog to digital conversion interval, the ADC converts the analog voltage to an equivalent digital output.
|
13. An analog to digital converter comprising:
a successive approximation analog-to-digital converter;
an integral c1 g0">switched capacitor amplifier; and
a differential amplifier comprising a negative input and a positive input, wherein the successive approximation analog-to-digital converter and the integral c1 g0">switched capacitor amplifier share the differential amplifier via connection to the negative input of the differential amplifier.
25. A method of converting an analog signal to a digital equivalent signal, comprising:
sensing an analog attribute of an analog signal using a differential amplifier configured in an operational amplifier mode, wherein the differential amplifier comprises a positive input, a negative input, and an output, wherein the negative input is electrically coupled to a sampling capacitor, and wherein the negative input and the output are electrically coupled to a c1 g0">switched capacitor array; and
converting the sensed analog attribute to a digital signal using the differential amplifier configured in a comparator mode.
19. A system comprising:
an analog-to-digital converter configured to convert an analog signal to a digital signal, the analog-to-digital converter including:
a differential amplifier comprising a positive input, a negative input, and an output, wherein the negative input is electrically coupled to an input capacitor, wherein the negative input and the output are electrically coupled to a c1 g0">switched capacitor array, wherein the differential amplifier is reconfigurable between an operational amplifier mode and a comparator mode; and
a controller configured to reconfigure the differential amplifier between the operational amplifier mode and the comparator mode.
1. An analog to digital converter (ADC) comprising:
a c1 g0">switched capacitor array having a total capacitance value of C2;
a differential amplifier selectably configurable as either an operational amplifier or a comparator, said differential amplifier having first and second inputs and an output, wherein the first input is coupled to a reference voltage and wherein the c1 g0">switched capacitor array is coupled across the second input and the output of the differential amplifier;
an input capacitor switchably coupled between the differential amplifier second input and an analog voltage source adapted to provide an analog voltage signal to be converted to a digital output signal, said input capacitor having a capacitance value of C1;
a successive approximation register coupled to the c1 g0">switched capacitor array and the differential amplifier output and configured to provide the digital output signal; and
a logic signal generator configured to provide timing control logic signals to the other components of the ADC.
2. The ADC of
3. The ADC of
4. The ADC of
5. The ADC of
6. The ADC of
7. The ADC of
8. The ADC of
9. The ADC of
10. The ADC of
11. The ADC of
12. The ADC of
14. The analog to digital converter of
15. The analog to digital converter of
16. The analog to digital converter of
17. The analog to digital converter of
18. The analog to digital converter of
20. The system of
22. The system of
24. The system of
26. The method of
28. The method of
sampling an electrode to charge an input capacitor to the voltage of the analog signal; and
transferring the voltage from the input capacitor to the c1 g0">switched capacitor array.
|
This application is a continuation of U.S. application Ser. No. 14/217,329, filed on Mar. 17, 2014, which claims the benefit of U.S. Provisional Application No. 61/788,926, filed on Mar. 15, 2013. The subject matter of the aforementioned applications are hereby incorporated by reference herein in their entirety.
The present invention relates to a successive approximation analog to digital converter capable of a broad range of uses and in particular to high voltage stimulation electrode monitoring especially in functional electrical stimulation (FES) applications.
Typically in FES applications, current pulses generated in a programmable current generator are applied to nerve tissue for stimulating the tissue through a plurality of selectable electrodes. For many applications, due to the required current pulse amplitudes and the impedance of the stimulated tissue and of the electrodes, a high compliance voltage is required for the stimulators. Compliance voltage is the voltage available at an electrode that can be used to force current to flow through the electrode and still maintain control of the electrode voltage.
In many applications measurements of the electrode voltages are necessary for maintaining the operational integrity of the stimulator circuits. Such samples would be required for example in the measurements and determination of tissue and electrode impedances as well as detecting the existence or absence of shorts or open circuits involving the electrodes. To accommodate digital processing circuitry typically utilized in biomedical devices, digitizing the analog signals normally sensed by the electrodes is often required. However, analog-to-digital converters (ADCs) are often designed using low voltage transistors for minimizing die area as well as power consumption. As a result, the high electrode voltages cannot be digitized directly. Attenuation of the electrode voltage to the input voltage range of the ADC is required.
A common technique to achieve attenuation is to use resistor voltage dividers to divide the high electrode voltage to a lower voltage. However, this technique is not suitable for an FES application since it will draw out current from the stimulator and hence, affecting the stimulation pulse amplitude as well as the output impedance of the stimulator. To alleviate these problems, a voltage buffer between the stimulator and the voltage divider can be added [See Lee, E., “High Voltage Tolerant Stimulation Monitoring Circuit in Conventional CMOS Process”, Proc. Of the IEEE 2009 Int. Custom Integrated Circuits Conference (CICC), pp. 93-96, September 2009]. However, such a voltage buffer is difficult to design due to the requirement for a high-voltage rail-to-rail operational amplifier (op amp).
Another possible technique is to use two switched-capacitors (SCs) as two separate resistors to form a voltage divider. In this way, no DC current is drawn out from the stimulator. However, the charge injection of the switches and the nonlinear parasitic capacitances at connection node of the two SCs will affect the accuracy of the attenuation gain as well as the linearity of the divider. Furthermore, an ADC usually has considerable input capacitance. When the ADC input is connected to the SC divider, it will affect the actual attenuation factor of the attenuator. Therefore, instead of using a simple SC voltage divider, a SC amplifier with a voltage gain equal to the required attenuation factor is typically used [See Lee, E., Dai, R., Reeves, N., and Yun, X., “A 36V Biphasic Stimulator with Electrode Monitoring Circuit”, Proc. of the 2012 IEEE Int. Symposium on Circuits and Systems, pp 1087-1090, May 2012]. The SC amplifier is not only used for driving the ADC but can also be used for eliminating the parasitic capacitance effects and possibly the charge injection effects. However, this design requires additional power to power the SC amplifier.
Among different ADC architectures, successive approximation ADCs using a SC array digital to analog converter is a popular architecture for biomedical applications since it requires low power consumption for the sampling rate required in most biomedical devices. Based on this type of ADC, one can combine the attenuation function into the ADC. An additional switched-capacitor can be added in series with the SC array at the input of the original ADC architecture [Thomas Paul Kearney, “Programmable Input Range SAR ADC”, U.S. Pat. No. 6,731,232]. By properly controlling the clock phases, attenuation can be achieved. Since now the input capacitance of the ADC (capacitance of the SC array) becomes part of the attenuator, no buffer or SC amplifier is required to drive the ADC input. However, the accuracy of the attenuation factor is still affected due to the nonlinear parasitic capacitances and charge injections of the switches. In some instances, what is needed therefore may be a new and novel successive approximation ADC architecture to remedy the deficiencies existing in the art as discussed above.
One non-limiting embodiment of the present invention includes a differential amplifier configurable as either an op amp or a comparator depending upon the particular mode of operation of the ADC. An input capacitor having a capacitance value of C1 is switchably coupled to an electrode selected for voltage sampling and a second input (negative input) of the differential amplifier. A reference voltage is applied to a first input (positive input) of the differential amplifier. A switched capacitor array having a total capacitance value of C2 is coupled across the second input and the differential amplifier output. The switched capacitor array may be a binary weighted array used for ADC purposes. A successive approximation register is coupled to the switched capacitor array and the differential amplifier output and provides a digital output corresponding to the sampled electrode analog voltage.
In some instances during a sampling interval, the input capacitor is charged to the sampled electrode analog voltage. Concurrently, the differential amplifier is configured as an op amp such that a virtual ground is established at the second input which provides for a path for charging the input capacitor up to the sampled electrode analog voltage.
In some instances during a transfer interval, the voltage on the input capacitor multiplied by the ratio C1/C2 is transferred to the switched capacitor array while the differential amplifier is maintained as being configured as an op amp.
In some instances during an analog to digital conversion interval, the differential amplifier is configured as a comparator and the switched capacitor array, the successive approximation register and the comparator undertake the conversion of the electrode analog voltage to an equivalent digital output.
In one embodiment the present disclosure relates to a peripherally-implantable neurostimulation system. The peripherally implantable neurostimulation system can include a plurality of leads that can each include at least one electrode, an analog-to-digital converter that can include, for example, a successive approximation analog-to-digital converter and an integral switched capacitor amplifier. In some embodiments, the successive approximation analog-to-digital converter and the integral switched capacitor amplifier can share a common differential amplifier. In some embodiments, the system includes a pulse generator that can generate one or several electrical pulses. In some embodiments, the pulse generator is connected to the leads such that the electrical pulses are transmitted to the at least one electrode.
In some embodiments, the peripherally-implantable neurostimulation system can include a successive approximation register. In some embodiments of the peripherally-implantable neurostimulation system, the successive approximation register can include a logic signal generator, which logic signal generator can generate a first signal directing the differential amplifier to operate as an opamp during a first period, and a second signal directing the differential amplifier to operate as a comparator during a second period. In some embodiments, the peripherally-implantable neurostimulation system can include an input capacitor between the leads and the analog-to-digital converter, which input capacitor can be charged during the first period. In some embodiments, the input capacitor can be discharged during the first period and subsequent to the charging of the input capacitor, and the charge the can be transferred to a switched capacitor array.
In one embodiments, the present disclosure relates to an implantable electrical stimulation system. The implantable electrical stimulation system can include a pulse generator that can generate one or several electrical pulses, an electrode array that can output the one or several electrical pulses, an analog-to-digital converter that can convert an analog signal associated with at least one of the electrodes of the electrode array to a digital signal, and that can include a reconfigurable differential amplifier, and a controller that can reconfigure the differential amplifier between an operational amplifier mode and a comparator mode.
In some embodiments of the implantable electrical stimulation system, the analog-to-digital converter can include a successive approximation analog-to-digital converter and a switched capacitor amplifier that share a common differential amplifier. In some embodiments, the implantable electrical stimulation system can include a successive approximation register.
In some embodiments of the implantable electrical stimulation system, the controller can generate a first signal directing the reconfigurable differential amplifier to operate as an opamp during a first period, and a second signal directing the differential amplifier to operate as a comparator during a second period. In some embodiments, the implantable electrical stimulation system can include an input capacitor connecting the leads and the analog-to-digital converter, which input capacitor can be charged during the first period. In some embodiments, the input capacitor is discharged during the first period and subsequent to the charging of the input capacitor, and the charge can be transferred to a switched capacitor array.
In one embodiment, the present disclosure relates to a method of treating neuropathic pain. The method of treating neuropathic pain can include delivering at least one electrical pulse to a body tissue proximate or at a nerve by an implanted pulse generator and at least one electrode, sensing an analog attribute of the at least one electrical pulse using a differential amplifier configured in an operational amplifier mode, and converting the sensed analog attribute to a digital signal using the differential amplifier configured in a comparator mode.
In some embodiments of the method of treating neuropathic pain, delivering the at least one electrical pulse can include delivering at least one electrical pulse to a peripheral body tissue proximate to or at a peripheral nerve. In some embodiments, the electrical pulse can have a first property, which first property can indicate the presence or absence of a short or open circuit and/or the voltage of the at least one electrode. In some embodiments, the method of treating neuropathic pain can include delivering a second electrical pulse having a second property. In some embodiments, the second property of the second electrical pulse can be based on the first property of the electrical pulse and the digital signal.
Referring now to
The switch array SE(j) is coupled to one input (negative input) of a configurable differential amplifier 16 through a series circuit arrangement with capacitor C1 and a switch S3. A reference voltage Vref is coupled to the other input (positive input) of differential amplifier 16. A second switch S2 is coupled between ground and the interconnection of the switch array SE(j) and capacitor C1. The state of switch S2 is controlled by the signal φ2 and the state of switch S3 is controlled by the signal φ3.
A switched capacitor array C2 (18), as shown in
Furthermore, in one embodiment, the 10 bit switched capacitor array 18 of
TRUTH TABLE FOR “B” SWITCHES IN SWITCHED
CAPACITOR ARRAY C2
For φ1 = 1, B(k) = 1 and B(k)b = 0
For φ2 = 1, B(k) = 0 and B(k)b = 0
For φ3 = 0, B(k) and B(k)b are complementary
An example of a DAC capacitor array for “n” bits can be found in a technical paper entitled “Capacitor Array Structure and Switch Control for Energy-Efficient SAR Analog-to-Digital Converters” by Jeong-Sup Lee and In-Cheol Park, IEEE Circuits and Systems, 2008. ISCAS 2008. May 18-21, 2008, pp. 236-239. Another reference to switched capacitor arrays appears in “Analog Integrated Circuit Design”, by David Johns and Ken Martin, John Wiley & Sons, 1997, pp. 492-496 and therefore operation of the switched capacitor array need not be described in detail.
A conventional successive approximation register (SAR) 22 is coupled to the switched capacitor array 18 and to the output 20 of differential amplifier 16. Timing control logic signals φ1, φ2 and φ3 as well as clocking signals CK and a start signal START are generated by a logic signal generator (not shown) contained within SAR 22 and applied for conventional SAR operation. Including the logic signal generator in the SAR 22 tends to reduce overall circuit area but having a logic signal generator outside of the SAR 22 as an independent circuit block is also within the contemplation of the invention. The logic signal generator generates the timing signals φ1, φ2 and φ3 for overall circuit operation. As is shown in
In operation, a particular electrode is selected for voltage sampling and switch SE(j), where “j” represents the number of the particular selected electrode, is high or at logic “1”. During the sample interval, that is, when the signal φ1 is high or at logic “1”, the voltage appearing at the selected electrode E(j) is sampled on capacitor C1. During the sample interval, charge transfers from the selected electrode output to capacitor C1 which causes capacitor C1 to charge up to the electrode output voltage. As noted above, during the sample interval, the configurable differential amplifier 16 functions as an op amp with unity gain feedback by virtue of switch S4 being closed (φ1 being high). By configuring the differential amplifier as an op amp during a sample interval, a virtual ground is established at the differential amplifier second input for facilitating charge transfer from the input capacitor C1 to the switched capacitor array. Furthermore, any voltage offsets (designated as Vos) attributable to op amp 16 are also sampled on capacitor C1. At the same time, the switches B(1) to B(10) are closed such that all the capacitors in the switched capacitor array 18 are coupled to voltage Vref. During the sampling interval, signal φ2 is low so that switch S2 is open and signal φ3 is high so that switch S3 is closed.
During the transfer interval, that is when the signal φ2 is high or logic “1”, all the capacitors in the switched capacitor array 18 are coupled to Vi (
It is also to be noted that the symbol C2 has a dual usage such that for purposes of forming the factor C1/C2, the symbol C2 represents the total capacitance value of all the capacitors in the switched capacitor array and for purposes of describing circuit operation, the symbol C2 represents circuit block 18 of
During the transfer interval, the signal φ1 is low so that switch S4 is open and signal φ3 is high so that switch S3 is closed. It is to be noted that during the transfer interval, the capacitors in the switched capacitor array are coupled between the differential amplifier output and the negative input, and are in a feedback loop due to φ2 being high, and differential amplifier 16 remains configured as an op amp.
This new and novel arrangement provides for the measurement of large electrode voltages by first attenuating the high electrode voltage range to a lower voltage range across capacitor C2. The attenuation factor is given precisely by the ratio of capacitors C1 and C2, which (unlike the prior art discussed previously) is not affected by any parasitic capacitance associated with capacitors C1 and C2. Since the voltage across capacitor C2 has a lower voltage range, low voltage circuits including logic circuits can be used for digitizing the voltage across capacitor C2. In addition, since low voltage circuits utilizing low voltage transistors that require small die areas are used, high voltage transistors (that occupy large die areas) are only required for switch S2 as well as the input switch array coupled between the electrode inputs and capacitor C1. As a result, this reduces the overall ADC die area when compared to circuits using high voltage transistors.
During the analog to digital conversion interval, that is when the signal φ3 is low or logic “0”, the differential amplifier 16 is configured as a comparator and the voltage VC2 is converted to digital bits (D1 to D10 assuming a 10 bit ADC architecture) in a manner similar to a conventional successive approximation ADC, by switching the capacitors in the switched capacitor array 18 between Vref and ground according to the comparison results generated by comparator 16. For the example 10 bit ADC, although a processor is not shown in the drawings, it is to be understood that a processor configured to undertake the switching activity in the switched capacitor array as well as processing in the successive approximation register (SAR) 22 is within the contemplation of the invention and well within the capabilities of those skilled in the art and therefore is not described here in detail. Upon completion of a successive approximation process during the analog to digital conversion interval, SAR 22 provides the analog to digital converted output at SAR output 24. It is also to be understood that whether done in SAR 22 or after the ADCO (SAR output 24) is generated, the actual converted voltage must be upscaled by the inverse of the attenuation factor C1/C2 or downscaled by the gain factor C1/C2 as the case may be, in order to obtain an accurate conversion of the selected electrode voltage.
With regard to the offset voltage Vos, it is considered that the voltage is unchanged during the sample interval and transfer interval due to proper design of the differential amplifier 16. Moreover, the offset voltage of differential amp 16 is cancelled by the offset voltage stored on capacitor C2.
With reference to
In some non-limiting embodiments, the afore described ADC architecture may be incorporated into an implantable electrical stimulation system, such as a peripherally implantable system for treating neuropathic pain.
Approximately 8% of the Western (EU and US) population is affected by Neuropathic pain (chronic intractable pain due to nerve damage). In about 5% of people, this pain is severe. There are at least 200,000 patients that have chronic intractable pain involving a nerve. Neuropathic pain can be very difficult to treat with only half of patients achieving partial relief. Thus, determining the best treatment for individual patients remains challenging. Conventional treatments include certain antidepressants, anti-epileptic drugs and opioids. However, side effects from these drugs can be detrimental. In some of these cases, electrical stimulation, including FES, can provide effect treatment of this pain without the drug-related side effects.
A spinal cord stimulator, which is one type of FES device, is a device used to deliver pulsed electrical signals to the spinal cord to control chronic pain. Because electrical stimulation is a purely electrical treatment and does not cause side effects similar to those caused by drugs, an increasing number of physicians and patients favor the use of electrical stimulation over drugs as a treatment for pain. The exact mechanisms of pain relief by spinal cord stimulation (SCS) are unknown. The scientific background of the SCS trials was based initially on the Gate Control Theory of pain that was first described by Melzack and Wall in 1965. The theory posits that pain is transmitted by two kinds of afferent nerve fibers. One is the larger myelinated Aδ fiber, which carries quick, intense-pain messages. The other is the smaller, unmyelinated “C” fiber, which transmits throbbing, chronic pain messages. A third type of nerve fiber, called Aβ, is “non-nociceptive,” meaning it does not transmit pain stimuli. The gate control theory asserts that signals transmitted by the Aδ and C pain fibers can be thwarted by the activation/stimulation of the non-nociceptive Aβ fibers and thus inhibit an individual's perception of pain. Thus, neurostimulation provides pain relief by blocking the pain messages before they reach the brain.
At the present time, SCS is used mostly in the treatment of failed back surgery syndrome, a complex regional pain syndrome that has refractory pain due to ischemia. SCS complications have been reported in 30% to 40% of all SCS patients. This increases the overall costs of patient pain management and decreases the efficacy of SCS. Common complications include: infection, hemorrhaging, injury of nerve tissue, placing device into the wrong compartment, hardware malfunction, lead migration, lead breakage, lead disconnection, lead erosion, pain at the implant site, generator overheating, and charger overheating. The occurrence rates of common complications are surprisingly high: 9.5% are accounted for lead extension connection issues, 6% are due to lead breakage, 22.6% of cases are associated with lead migration and 4.5% experienced infection.
Peripheral neuropathy may be either inherited or acquired. Causes of acquired peripheral neuropathy include physical injury (trauma) to a nerve, viruses, tumors, toxins, autoimmune responses, nutritional deficiencies, alcoholism, diabetes, and vascular and metabolic disorders. Acquired peripheral neuropathies are grouped into three broad categories: those caused by systemic disease, those caused by trauma, and those caused by infections or autoimmune disorders affecting nerve tissue. One example of an acquired peripheral neuropathy is trigeminal neuralgia, in which damage to the trigeminal nerve (the large nerve of the head and face) causes episodic attacks of excruciating, lightning-like pain on one side of the face.
A high percentage of patients with peripheral neuropathic pain do not benefit from SCS for various reasons. However, many of these patients can receive acceptable levels of pain relief via direct electrical stimulation to the corresponding peripheral nerves. This therapy is called peripheral nerve stimulation (PNS). There is, however, no FDA approved PNS devices in the US market. Standard spinal cord stimulator (SCS) devices are often used off label by pain physicians to treat this condition. It is estimated that about 15% of SCS devices have been used off-label for PNS.
As current commercially-available SCS systems were designed for stimulating the spinal cord and not for peripheral nerve stimulation, there are more device complications associated with the use of SCS systems for PNS than for SCS. Current SCS devices (generators) are large and bulky. In the event that an SCS is used for PNS, the SCS generator is typically implanted in the abdominal or in the lower back above the buttocks and long leads are tunneled across multiple joints to reach the target peripheral nerves in the arms, legs or face. The excessive tunneling and the crossing of joints leads to increased post-surgical pain and higher device failure rates. Additionally, rigid leads can lead to skin erosion and penetration, with lead failure rates nearing 100% within 3 years of implantation. Most complications result in replacement surgery and even multiple replacement surgeries in some cases.
One embodiment of a sensing system 500 of a peripherally-implantable neurostimulation system is shown in
In some embodiments, the analog-to-digital converter 502 can include one or several space saving features. In one embodiment, for example, the analog-to-digital converter 502 can include one or several switched capacitors, which can be, for example, part of a switched capacitor amplifier. In one embodiment, the switched capacitor amplifier can be combined with a successive approximation analog-to-digital converter, which successive approximation analog-to-digital converter can include a comparator. The combination of the switched capacitor amplifier and the successive approximation analog-to-digital converter is shown in
As seen in
One embodiment of a peripherally-implantable neurostimulation system 600 is shown in
The peripherally-implantable neurostimulation system 600 can include one or several pulse generators. The pulse generators can comprise a variety of shapes and sizes, and can be made from a variety of materials. In some embodiments, the one or several pulse generators can generate electrical pulses that are delivered to a nerve to control pain. In some embodiments, a pulse generator can be an external pulse generator 602 or an implantable pulse generator 604. In some embodiments, an external pulse generator 602 can be used to evaluate the suitability of a patient for treatment with the peripherally-implantable neurostimulation system 600 and/or for implantation of an implantable pulse generator 604.
The implantable pulse generator 604 can be sized and shaped, and made of material so as to allow implantation of the implantable pulse generator 604 inside of a body. In some embodiments, the implantable pulse generator 604 can be sized and shaped so as to allow placement of the implantable pulse generator 604 at any desired location in a body, and in some embodiments, placed proximate to a peripheral nerve such that leads (discussed below) are not tunneled across joints and/or such that extension cables are not needed. In some embodiments, the pulse generator, and specifically the implantable pulse generator 604 and/or the external pulse generator 602 can incorporate the sensing system of
In some embodiments, the electrical pulses generated by the pulse generator can be delivered to one or several nerves 610 and/or to tissue proximate to one or several nerves 610 via one or several leads. The leads can include conductive portions, referred to as electrodes, and non-conductive portions. The leads can have a variety of shapes, can be in a variety of sizes, and can be made from a variety of materials, which size, shape, and materials can be dictated by the application or other factors.
In some embodiments, the leads can include an anodic lead 606 and/or a cathodic lead 608. In some embodiments, the anodic lead 606 and the cathodic lead 608 can be identical leads, but can receive pulses of different polarity from the pulse generator.
In some embodiments, the leads can connect directly to the pulse generator, and in some embodiments, the leads can be connected to the pulse generator via a connector 612 and a connector cable 614. The connector 612 can comprise any device that is able to electrically connect the leads to the connector cable 614. Likewise, the connector cable can be any device capable of transmitting distinct electrical pulses to the anodic lead 606 and the cathodic lead 608.
In some embodiments, the peripherally-implantable neurostimulation system 600 can include a charger 616 that can be configured to recharge the implantable pulse generator 604 when the implantable pulse generator 604 is implanted within a body. The charger 616 can comprise a variety of shapes, sizes, and features, and can be made from a variety of materials. In some embodiments, the charger 616 can recharge the implantable pulse generator 604 via an inductive coupling.
In some embodiments, one or several properties of the electrical pulses can be controlled via a controller. In some embodiments, these properties can include, for example, the frequency, strength, pattern, duration, or other aspects of the timing and magnitude of the electrical pulses. In one embodiment, these properties can include, for example, a voltage, a current, or the like. In one embodiment, a first electrical pulse can have a first property and a second electrical pulse can have a second property. This control of the electrical pulses can include the creation of one or several electrical pulse programs, plans, or patterns, and in some embodiments, this can include the selection of one or several pre-existing electrical pulse programs, plans, or patterns. In the embodiment depicted in
In some embodiments, the controller of the peripherally-implantable neurostimulation system 600 can include a patient remote 620. The patient remote 620 can comprise a computing device that can communicate with the pulse generators via a wired or wireless connection. The patient remote 620 can be used to program the pulse generator, and in some embodiments, the patient remote 620 can include one or several pulse generation programs, plans, or patterns created by the clinician programmer 618. In some embodiments, the patient remote 620 can be used to select one or several of the pre-existing pulse generation programs, plans, or patterns and to select, for example, the duration of the selected one of the one or several pulse generation programs, plans, or patterns.
Advantageously, the above outlined components of the peripherally-implantable neurostimulation system 600 can be used to control and provide the generation of electrical pulses to mitigate patient pain.
While the invention has been described by means of specific embodiments and applications thereof, it is understood that numerous modifications and variations could be made thereto by those skilled in the art without departing from the spirit and scope of the invention. It is therefore to be understood that within the scope of the claims, the invention may be practiced otherwise than as specifically described herein. For example, although certain electronic devices were described as being coupled to specific positive and negative inputs of the differential amplifier it is to be understood that other connection assignments for such electronic devices is contemplated by the invention with corresponding adjustments made to logic signal timing and signal processing to achieve desired ADC operation.
Patent | Priority | Assignee | Title |
Patent | Priority | Assignee | Title |
3646940, | |||
3942535, | Sep 27 1973 | SIEMENS-ELEMA AB, A CORP OF SWEDEN | Rechargeable tissue stimulating system |
4019518, | Aug 11 1975 | Medtronic, Inc. | Electrical stimulation system |
4044774, | Feb 23 1976 | Medtronic, Inc. | Percutaneously inserted spinal cord stimulation lead |
4082097, | May 20 1976 | Pacesetter AB | Multimode recharging system for living tissue stimulators |
4340062, | Nov 06 1978 | MED REL, INC | Body stimulator having selectable stimulation energy levels |
4468723, | Apr 24 1981 | Hewlett-Packard Company | Magnetically regulated power supply |
4558702, | Jan 21 1983 | Pacesetter, Inc | Cardiac pacer having input/output circuit programmable for use with unipolar and bipolar pacer leads |
4673867, | Jun 30 1986 | Semiconductor Components Industries, L L C | Current mirror circuit and method for providing zero temperature coefficient trimmable current ratios |
4744371, | Apr 27 1987 | Pacesetter, Inc | Multi-conductor lead assembly for temporary use |
5143089, | May 03 1989 | ADVANCED MEDICAL DEVICES, S A | Assembly and method of communicating electrical signals between electrical therapeutic systems and body tissue |
5690693, | Jun 07 1995 | Intermedics Inc | Transcutaneous energy transmission circuit for implantable medical device |
5702428, | May 23 1992 | Axelgaard Manufacturing Company, Ltd. | Electrical stimulation for treatment of incontinence and other neuro-muscular disorders |
5702431, | Jun 07 1995 | Sulzer Intermedics Inc. | Enhanced transcutaneous recharging system for battery powered implantable medical device |
5735887, | Dec 10 1996 | Medtronic, Inc | Closed-loop, RF-coupled implanted medical device |
5741316, | Dec 02 1996 | PURDUE PHARMACEUTICAL PRODUCTS L P | Electromagnetic coil configurations for power transmission through tissue |
5835049, | Mar 27 1997 | AVAGO TECHNOLOGIES GENERAL IP SINGAPORE PTE LTD | Amplifier for use in time-sharing applications |
5876423, | Jun 04 1996 | BIOTRONIK MESS-UND THERAPIEGERAETE GMBH & CO | Implantable stimulator with terminal voltage control of a depletable voltage source |
5877472, | Feb 22 1996 | Pacesetter, Inc.; Pacesetter, Inc | System for laser-welding components of an implantable device |
6027456, | Jul 10 1998 | ADVANCED NEUROMODULATION SYSTEMS, INC | Apparatus and method for positioning spinal cord stimulation leads |
6035237, | May 23 1995 | ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH | Implantable stimulator that prevents DC current flow without the use of discrete output coupling capacitors |
6055456, | Apr 29 1999 | Medtronic, Inc. | Single and multi-polar implantable lead for sacral nerve electrical stimulation |
6057513, | Jan 29 1997 | NGK Insulators, Ltd | Joint structure of metal member and ceramic member and method of producing the same |
6067474, | Aug 01 1997 | Advanced Bionics AG | Implantable device with improved battery recharging and powering configuration |
6076017, | Apr 30 1997 | Medtronic, Inc. | Method of centerless ground finishing of feedthrough pins for an implantable medical device |
6164284, | Feb 26 1997 | ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH | System of implantable devices for monitoring and/or affecting body parameters |
6172556, | Mar 04 1999 | Synaptics Incorporated | Feedback-controlled low voltage current sink/source |
6178353, | Jul 27 1998 | Advanced Bionics AG | Laminated magnet keeper for implant device |
6185452, | Feb 26 1997 | ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH | Battery-powered patient implantable device |
6191365, | Nov 04 1997 | AVELLANET, FRANCISCO J | Medical devices incorporating at least one element made from a plurality of twisted and drawn wires |
6208894, | Feb 26 1997 | Boston Scientific Neuromodulation Corporation | System of implantable devices for monitoring and/or affecting body parameters |
6212431, | Sep 08 1998 | Advanced Bionics AG | Power transfer circuit for implanted devices |
6221513, | May 12 1998 | PACIFIC AEROSPACE & ELECTRONICS, LLC; HERMETIC SOLUTIONS GROUP INC ; FILCONN, LLC | Methods for hermetically sealing ceramic to metallic surfaces and assemblies incorporating such seals |
6246911, | Feb 08 1999 | Cochlear Limited | Cochlear implants with offset coils for transmission of radio frequency links |
6249703, | Jul 08 1994 | Medtronic, Inc | Handheld patient programmer for implantable human tissue stimulator |
6265789, | Nov 20 1997 | 138 EAST LCD ADVANCEMENTS LIMITED | Electronic apparatus |
6306100, | Dec 16 1997 | Intraoperative neurophysiological monitoring system | |
6307497, | Jun 19 2000 | SILICON LABS CP, INC | Programmable gain ADC |
6313779, | Jun 19 2000 | SILICON LABS CP, INC | Comparator-amplifier configuration in an ADC |
6315721, | Feb 26 1997 | Boston Scientific Neuromodulation Corporation | System of implantable devices for monitoring and/or affecting body parameters |
6354991, | Oct 06 1998 | AMS Research Corporation | Incontinence treatment device |
6360750, | Apr 29 1999 | Medtronic, Inc | Minimally invasive surgical techniques for implanting devices that deliver stimulant to the nervous system |
6393325, | Jan 07 1999 | Boston Scientific Neuromodulation Corporation | Directional programming for implantable electrode arrays |
6427086, | Oct 27 1997 | NeuroPace, Inc | Means and method for the intracranial placement of a neurostimulator |
6438423, | Jan 20 2000 | ElectroCore Technique, LLC; ElectroCore Techniques, LLC | Method of treating complex regional pain syndromes by electrical stimulation of the sympathetic nerve chain |
6442434, | Oct 19 1999 | ABIOMED, INC | Methods and apparatus for providing a sufficiently stable power to a load in an energy transfer system |
6466817, | Nov 24 1999 | NuVasive, Inc | Nerve proximity and status detection system and method |
6505075, | May 29 1999 | Peripheral nerve stimulation method | |
6516227, | Jul 27 1999 | Boston Scientific Neuromodulation Corporation | Rechargeable spinal cord stimulator system |
6521350, | Jun 18 2001 | Alfred E. Mann Foundation for Scientific Research | Application and manufacturing method for a ceramic to metal seal |
6564807, | Feb 26 1997 | Alfred E. Mann Foundation for Scientific Research | System of implantable devices for monitoring and/or affecting body parameters |
6584355, | Apr 10 2001 | Cardiac Pacemakers, Inc. | System and method for measuring battery current |
6600954, | Jan 25 2001 | Medtronic, Inc | Method and apparatus for selective control of nerve fibers |
6609031, | Jun 07 1996 | ADVANCED NEUROMODULATION SYSTEMS, INC | Multiprogrammable tissue stimulator and method |
6609032, | Jan 07 1999 | Boston Scientific Neuromodulation Corporation | Fitting process for a neural stimulation system |
6652449, | Oct 06 1998 | ASTORA WOMEN S HEALTH, LLC | Control of urge incontinence |
6662051, | Mar 31 2000 | Programmable pain reduction device | |
6721603, | Jan 25 2002 | ZABARA, JACOB | Nerve stimulation as a treatment for pain |
6735474, | Jul 06 1998 | Boston Scientific Neuromodulation Corporation | Implantable stimulator system and method for treatment of incontinence and pain |
6745077, | Oct 11 2000 | Advanced Bionics AG | Electronic impedance transformer for inductively-coupled load stabilization |
6809701, | Aug 03 2001 | Cardiac Pacemakers, Inc. | Circumferential antenna for an implantable medical device |
6836684, | Oct 29 1999 | Neurocon ApS | Method to control an overactive bladder |
6847849, | Nov 15 2000 | MAMO, LAURA | Minimally invasive apparatus for implanting a sacral stimulation lead |
6864755, | Oct 06 2000 | THE ALFRED E MANN INSTITUTE FOR BIOMEDICAL ENGINEERING AT THE UNIVERSITY OF SOUTHERN CALIFORNIA | Switched reactance modulated E-class oscillator design |
6892098, | Apr 26 2001 | BIO CONTROL MEDICAL B C M LTD | Nerve stimulation for treating spasticity, tremor, muscle weakness, and other motor disorders |
6895280, | Jul 27 1999 | Boston Scientific Neuromodulation Corporation | Rechargeable spinal cord stimulator system |
6896651, | Oct 06 1998 | Medtronic, Inc | Mechanical and electrical sensing for incontinence treatment |
6901287, | Feb 09 2001 | Medtronic INC; Medtronic, Inc | Implantable therapy delivery element adjustable anchor |
6941171, | Jul 06 1998 | Boston Scientific Neuromodulation Corporation | Implantable stimulator methods for treatment of incontinence and pain |
6971393, | Nov 15 2000 | MAMO, LAURA | Minimally invasive method for implanting a sacral stimulation lead |
6986453, | Nov 13 2003 | Alfred E. Mann Foundation for Scientific Research; ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH | Manufacturing method for a ceramic to metal seal |
6989200, | Oct 30 2003 | ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH, THE | Ceramic to noble metal braze and method of manufacture |
6990376, | Dec 06 2002 | Regents of the University of California, The | Methods and systems for selective control of bladder function |
6999819, | Aug 31 2001 | MAMO, LAURA | Implantable medical electrical stimulation lead fixation method and apparatus |
7051419, | Sep 16 1999 | ADVANCED NEUROMODULATION SYSTEMS, INC | Neurostimulating lead |
7054689, | Aug 18 2000 | Boston Scientific Neuromodulation Corporation | Fully implantable neurostimulator for autonomic nerve fiber stimulation as a therapy for urinary and bowel dysfunction |
7069081, | Feb 08 2001 | GREATBATCH, LTD NEW YORK CORPORATION | One piece header assembly for an implantable medical device |
7114502, | Feb 26 1997 | Alfred E. Mann Foundation for Scientific Research | Battery-powered patient implantable device |
7127298, | Oct 18 2002 | Boston Scientific Neuromodulation Corporation | Switched-matrix output for multi-channel implantable stimulator |
7142925, | Sep 16 1998 | AXON ENGINEERING, INC | Combined stimulation of ventral and dorsal sacral roots for control of bladder function |
7146219, | Oct 31 2002 | Medtronic, Inc | Applying filter information to identify combinations of electrodes |
7151914, | Aug 21 2001 | Medtronic, Inc | Transmitter system for wireless communication with implanted devices |
7167749, | Nov 05 2002 | GREATBATCH, LTD NEW YORK CORPORATION | One piece header assembly for an implantable medical device |
7177690, | Jul 27 1999 | Boston Scientific Neuromodulation Corporation | Implantable system having rechargeable battery indicator |
7177698, | Jun 28 2002 | Boston Scientific Neuromodulation Corporation | Telemetry system for use with microstimulator |
7181286, | Oct 31 2002 | Medtronic, Inc | Distributed system for neurostimulation therapy programming |
7187978, | Nov 01 2001 | Medtronic, Inc | Method and apparatus for programming an implantable medical device |
7191005, | Apr 10 2001 | Cardiac Pacemakers, Inc. | System and method for measuring battery current |
7212110, | Apr 19 2004 | Advanced Neuromodulation Systems, Inc. | Implantable device and system and method for wireless communication |
7225032, | Oct 02 2003 | Medtronic, Inc | External power source, charger and system for an implantable medical device having thermal characteristics and method therefore |
7231254, | Aug 05 1998 | DiLorenzo Biomedical, LLC | Closed-loop feedback-driven neuromodulation |
7234853, | Aug 07 2000 | LUMINEX S P A | Textile product with illuminated fibers manufacturing process |
7245972, | Apr 29 2004 | Alfred E. Mann Foundation for Scientific Research | Electrical treatment to treat shoulder subluxation |
7286880, | Oct 02 2003 | Medtronic, Inc | System and method for transcutaneous energy transfer achieving high efficiency |
7305268, | Jul 13 2000 | ADVANCED NEUROMODULATION SYSTEMS, INC | Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators |
7317948, | Feb 12 2002 | Boston Scientific Neuromodulation Corporation | Neural stimulation system providing auto adjustment of stimulus output as a function of sensed impedance |
7324852, | Feb 25 2004 | Thomas Jefferson University | System and method for neurological stimulation of peripheral nerves to treat low back pain |
7324853, | Aug 31 2001 | Medtronic, Inc | Nerve stimulation for treating spasticity, tremor, muscle weakness, and other motor disorders |
7328068, | Nov 26 2003 | Medtronic, Inc | Method, system and device for treating disorders of the pelvic floor by means of electrical stimulation of the pudendal and associated nerves, and the optional delivery of drugs in association therewith |
7330764, | Aug 31 2001 | Medtronic, Inc. | Implantable medical electrical stimulation lead fixation method and apparatus |
7331499, | Nov 13 2003 | Alfred E. Mann Foundation for Scientific Research | Manufacturing method for a ceramic to metal seal |
7359751, | May 05 2004 | Advanced Neuromodulation Systems, Inc.; ADVANCED NEUROMODULATION SYSTEMS, INC | Clinician programmer for use with trial stimulator |
7369894, | Sep 06 2002 | Medtronic, Inc | Method, system and device for treating disorders of the pelvic floor by electrical stimulation of the sacral and/or pudendal nerves |
7386348, | Sep 29 1999 | Medtronic, Inc. | Patient interactive neurostimulation system and method |
7387603, | Oct 06 1998 | ASTORA WOMEN S HEALTH, LLC | Incontinence treatment device |
7396265, | Sep 30 2002 | Cochlear Limited | Feedthrough for electrical connectors |
7415308, | Feb 23 2005 | Medtronic, Inc | Implantable medical device providing adaptive neurostimulation therapy for incontinence |
7444181, | Dec 14 2005 | Boston Scientific Neuromodulation Corporation | Techniques for sensing and adjusting a compliance voltage in an implantable stimulator device |
7450991, | May 28 2004 | Advanced Neuromodulation Systems, Inc. | Systems and methods used to reserve a constant battery capacity |
7460911, | Feb 26 1997 | ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH, THE | System and method suitable for treatment of a patient with a neurological deficit by sequentially stimulating neural pathways using a system of discrete implantable medical devices |
7463928, | Apr 25 2003 | Medtronic, Inc. | Identifying combinations of electrodes for neurostimulation therapy |
7470236, | Nov 24 1999 | NuVasive, Inc | Electromyography system |
7483752, | Mar 02 2001 | Cardiac Pacemakers, Inc. | Antenna for an implantable medical device |
7496404, | Jul 27 1999 | Boston Scientific Neuromodulation Corporation | Rechargeable spinal cord stimulator system |
7513257, | Feb 26 1997 | Alfred E. Mann Foundation for Scientific Research | System of implantable devices for monitoring and/or affecting body parameters |
7515967, | Oct 02 2003 | Medtronic, Inc | Ambulatory energy transfer system for an implantable medical device and method therefore |
7532936, | Apr 20 2004 | ADVANCED NEUROMODULATIN SYSTEMS, INC | Programmable switching device for implantable device |
7539538, | May 28 2004 | Boston Scientific Neuromodulation Corporation | Low power loss current digital-to-analog converter used in an implantable pulse generator |
7551960, | Sep 08 2005 | Medtronic, Inc | External presentation of electrical stimulation parameters |
7555346, | Jan 07 1999 | Boston Scientific Neuromodulation Corporation | Implantable pulse generator having current steering means |
7565203, | Mar 24 1999 | Second Sight Medical Products, Inc. | Package for an implantable medical device |
7578819, | May 16 2005 | SPINAL ELEMENTS, INC | Spinal access and neural localization |
7580752, | Feb 23 2005 | Medtronic, Inc | Implantable medical device providing adaptive neurostimulation therapy for incontinence |
7582053, | Oct 06 1998 | Medtronic, Inc | Control of urge incontinence |
7617002, | Sep 15 2003 | Medtronic, Inc. | Selection of neurostimulator parameter configurations using decision trees |
7640059, | Sep 08 2005 | Medtronic, Inc | External presentation of electrical stimulation parameters |
7643880, | Dec 06 2002 | The Regents of the University of California | Methods and systems for selectively inhibiting neural transmission of somatic fibers |
7706889, | Apr 28 2006 | Medtronic, Inc | Tree-based electrical stimulator programming |
7720547, | Jan 04 2006 | Kenergy, Inc. | Extracorporeal power supply with a wireless feedback system for an implanted medical device |
7725191, | Mar 24 1999 | Second Sight Medical Products, Inc. | Package for an implantable device |
7734355, | Aug 31 2001 | Medtronic, Inc | Treatment of disorders by unidirectional nerve stimulation |
7738963, | Mar 04 2004 | ADVANCED NEUROMODULATION SYSTEMS, INC | System and method for programming an implantable pulse generator |
7738965, | Apr 28 2006 | Medtronic, Inc | Holster for charging pectorally implanted medical devices |
7741981, | Dec 30 2008 | HONG KONG APPLIED SCIENCE AND TECHNOLOGY RESEARCH INSTITUTE CO, LTD | Dual-use comparator/op amp for use as both a successive-approximation ADC and DAC |
7747330, | Mar 09 2006 | Medtronic, Inc | Global parameter adjustment for multiple stimulation programs |
7771838, | Oct 12 2004 | Boston Scientific Neuromodulation Corporation | Hermetically bonding ceramic and titanium with a Ti-Pd braze interface |
7774069, | Apr 29 2005 | Medtronic, Inc | Alignment indication for transcutaneous energy transfer |
7801619, | Apr 28 2006 | Medtronic, Inc | Tree-based electrical stimulator programming for pain therapy |
7813803, | Jun 09 2005 | Medtronic, Inc | Regional therapies for treatment of pain |
7813809, | Jun 10 2004 | MEDTRONIC URINARY SOLUTIONS, INC | Implantable pulse generator for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
7826901, | Apr 25 2003 | Medtronic, Inc | Generation of therapy programs and program groups |
7848818, | Feb 25 2004 | System and method for neurological stimulation of peripheral nerves to treat low back pain | |
7904167, | Jun 28 2002 | Boston Scientific Neuromodulation Corporation | Telemetry system for use with microstimulator |
7912555, | Aug 31 2001 | Medtronic, Inc. | Implantable medical electrical stimulation lead fixation method and apparatus |
7925357, | Apr 28 2006 | Medtronic, Inc | Holster for charging pectorally implanted medical devices |
7932696, | May 14 2007 | Boston Scientific Neuromodulation Corporation | Charger alignment indicator with adjustable threshold |
7933656, | Oct 31 2002 | Medtronic, Inc. | Distributed system for neurostimulation therapy programming |
7935051, | Jun 26 2002 | NuVasive, Inc. | Surgical access system and related methods |
7937158, | May 05 2004 | Advanced Neuromodulation Systems, Inc. | Multi-programmable trial stimulator |
7952349, | Dec 09 2002 | FERRO SOLUTIONS, INC | Apparatus and method utilizing magnetic field |
7957818, | Jun 26 2008 | CIRTEC MEDICAL CORP | Stimulation lead design and method of manufacture |
7979119, | Apr 26 2005 | Boston Scientific Neuromodulation Corporation | Display graphics for use in stimulation therapies |
7979126, | Oct 18 2006 | Boston Scientific Neuromodulation Corporation | Orientation-independent implantable pulse generator |
7988507, | Sep 30 2002 | Cochlear Limited | Feedthrough for electrical connectors |
8000782, | Sep 25 2002 | NuVasive, Inc. | System and methods for performing surgical procedures and assessments |
8000805, | Aug 31 2001 | Medtronic, Inc. | Implantable medical lead including tine markers |
8005535, | Sep 25 2001 | NuVasive, Inc. | System and methods for performing surgical procedures and assessments |
8005549, | Sep 13 2007 | Medtronic, Inc | Medical electrical lead |
8005550, | Sep 13 2007 | Medtronic, Inc | Medical electrical lead |
8019423, | Feb 17 2006 | Laparoscopic implantation of neurostimulators | |
8024047, | Apr 29 2005 | Medtronic, Inc. | Alignment indication for transcutaneous energy transfer |
8036756, | Aug 31 2001 | Medtronics Inc | Implantable medical electrical stimulation lead fixation method and apparatus |
8044635, | May 14 2007 | Boston Scientific Neuromodulation Corporation | Charger alignment indicator with adjustable threshold |
8050769, | Jul 11 2002 | NuVasive, Inc. | System and methods for determining nerve proximity, direction, and pathology during surgery |
8055337, | Jul 24 2008 | Boston Scientific Neuromodulation Corporation | System and method for maintaining a distribution of currents in an electrode array using independent voltage sources |
8068912, | Jul 11 2001 | NuVasive, Inc | System and methods for determining nerve proximity, direction, and pathology during surgery |
8083663, | Oct 06 1998 | ASTORA WOMEN S HEALTH, LLC | Pelvic disorder treatment |
8103360, | May 09 2008 | Cardiac Pacemakers, Inc | Medical lead coil conductor with spacer element |
8116862, | Jun 08 2006 | Greatbatch Ltd. | Tank filters placed in series with the lead wires or circuits of active medical devices to enhance MRI compatibility |
8121701, | Jan 07 1999 | Boston Scientific Neuromodulation Corporation | System and method for displaying stimulation field generated by electrode array |
8129942, | Jul 30 2005 | LS CABLE & SYSTEM LTD | Contactless charging method for charging battery |
8131358, | Jul 24 2008 | Boston Scientific Neuromodulation Corporation | System and method for maintaining a distribution of currents in an electrode array using independent voltage sources |
8140168, | Oct 02 2003 | Medtronic, Inc | External power source for an implantable medical device having an adjustable carrier frequency and system and method related therefore |
8145324, | Apr 13 2001 | Greatbatch Ltd | Implantable lead bandstop filter employing an inductive coil with parasitic capacitance to enhance MRI compatibility of active medical devices |
8150530, | Apr 28 2005 | Medtronic, Inc. | Activity sensing for stimulator control |
8175717, | Sep 06 2005 | Boston Scientific Neuromodulation Corporation | Ultracapacitor powered implantable pulse generator with dedicated power supply |
8180451, | Mar 04 2004 | Advanced Neuromodulation Systems, Inc. | System and method for programming an implantable pulse generator |
8180452, | Apr 20 2000 | Cochlear Limited | Transcutaneous power optimization circuit for a medical implant |
8180461, | Nov 15 2000 | Medtronics, Inc. | Minimally invasive apparatus for implanting a sacral stimulation lead |
8214042, | May 26 2009 | Boston Scientific Neuromodulation Corporation | Techniques for controlling charging of batteries in an external charger and an implantable medical device |
8214048, | Aug 18 2000 | Boston Scientific Neuromodulation Corporation | Fully implantable neurostimulator for autonomic nerve fiber stimulation as a therapy for urinary and bowel dysfunction |
8214051, | Oct 31 2002 | Medtronic, Inc. | Distributed system for neurostimulation therapy programming |
8219196, | Oct 31 2008 | Medtronic, Inc.; Medtronic, Inc | Determination of stimulation output capabilities throughout power source voltage range |
8219202, | Apr 28 2006 | Medtronic, Inc | Electrical stimulation of ilioinguinal nerve to alleviate chronic pelvic pain |
8233990, | Sep 15 2003 | Medtronic, Inc. | Selection of neurostimulator parameter configurations using decision trees |
8255057, | Jan 29 2009 | CRG SERVICING LLC, | Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions |
8311636, | Apr 28 2006 | Medtronic, Inc. | Tree-based electrical stimulator programming |
8314594, | Apr 30 2008 | Medtronic, Inc | Capacity fade adjusted charge level or recharge interval of a rechargeable power source of an implantable medical device, system and method |
8332040, | Mar 10 2008 | Advanced Neuromodulation Systems, Inc. | External charging device for charging an implantable medical device and methods of regulating duty of cycle of an external charging device |
8340786, | Oct 06 1998 | ASTORA WOMEN S HEALTH, LLC | Incontinence treatment device |
8362742, | Oct 26 2007 | Medtronic, Inc | Method and apparatus for dynamic adjustment of recharge parameters |
8369943, | Jun 06 2006 | Cardiac Pacemakers, Inc. | Method and apparatus for neural stimulation via the lymphatic system |
8386048, | Jun 28 2002 | Boston Scientific Neuromodulation Corporation | Systems and methods for communicating with or providing power to an implantable stimulator |
8417346, | Apr 28 2006 | Medtronic, Inc. | Electrical stimulation of iliohypogastric nerve to alleviate chronic pelvic pain |
8423146, | Jan 31 2006 | Medtronic, Inc. | Electrical stimulation to alleviate chronic pelvic pain |
8447402, | Mar 31 2006 | Alfred E. Mann Foundation for Scientific Research | Zirconia to platinum assembly using a titanium connector |
8447408, | Oct 31 2002 | Medtronic, Inc. | Neurostimulation therapy manipulation |
8457756, | Nov 11 2009 | Boston Scientific Neuromodulation Corporation | Using the case of an implantable medical device to broaden communication bandwidth |
8457758, | Apr 29 2005 | Medtronic, Inc. | Alignment indication for transcutaneous energy transfer |
8480437, | Apr 11 2008 | Bal Seal Engineering, Inc. | Connector cartridge stack for electrical transmission |
8494625, | Feb 04 2002 | HARGROVE, JEFFREY B | Methods and apparatus for electrical stimulation of tissues using signals that minimize the effects of tissue impedance |
8515545, | Apr 29 2011 | CIRTEC MEDICAL CORP | Current steering neurostimulator device with unidirectional current sources |
8538530, | Nov 19 2008 | Advanced Bionics AG | Hermetically sealed feedthrough case |
8543223, | Mar 11 2011 | CIRTEC MEDICAL CORP | Implantable lead with braided conductors |
8549015, | May 01 2007 | Method and system for distinguishing nociceptive pain from neuropathic pain | |
8554322, | Oct 02 2003 | Medtronic, Inc. | Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device |
8555894, | Feb 26 1997 | ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH, THE | System for monitoring temperature |
8562539, | Nov 24 1999 | NuVasive, Inc. | Electromyography system |
8571677, | Oct 21 2009 | Medtronic, Inc | Programming techniques for stimulation with utilization of case electrode |
8577474, | Nov 11 2009 | Boston Scientific Neuromodulation Corporation | Minimizing interference between charging and telemetry coils in an implantable medical device |
8588917, | Aug 18 2000 | Boston Scientific Neuromodulation Corporation | Fully implantable neurostimulator for autonomic nerve fiber stimulation as a therapy for urinary and bowel dysfunction |
8626314, | Aug 31 2001 | Medtronic, Inc. | Implantable medical lead including a plurality of tine elements |
8644933, | May 26 2009 | Boston Scientific Neuromodulation Corporation | Techniques for controlling charging of batteries in an external charger and an implantable medical device |
8655451, | Jun 28 2002 | Boston Scientific Neuromodulation Corporation | Telemetry system for use with microstimulator |
8700175, | Jul 19 2011 | CIRTEC MEDICAL CORP | Devices and methods for visually indicating the alignment of a transcutaneous energy transfer device over an implanted medical device |
8725269, | Mar 09 2006 | Medtronic, Inc. | Global parameter adjustment for multiple stimulation programs |
8738141, | Apr 07 2011 | CIRTEC MEDICAL CORP | Contact assembly for implantable pulse generator and method of use |
8738148, | Apr 29 2005 | Medtronic, Inc. | Alignment indication for transcutaneous energy transfer |
8750985, | May 28 2004 | Boston Scientific Neuromodulation Corporation | Low power loss current digital-to-analog converter used in an implantable pulse generator |
8761897, | Aug 31 2012 | CIRTEC MEDICAL CORP | Method and system of graphical representation of lead connector block and implantable pulse generators on a clinician programmer |
8768452, | Feb 23 2005 | Medtronic, Inc | Implantable neurostimulator supporting trial and chronic modes |
8774912, | Feb 23 2005 | Medtronic, Inc | Implantable neurostimulator supporting trial and chronic modes |
8954148, | Jun 28 2011 | CIRTEC MEDICAL CORP | Key fob controller for an implantable neurostimulator |
8989861, | Jun 07 2010 | Medtronic, Inc | Stimulation therapy for bladder dysfunction |
9089712, | Apr 29 2011 | LivaNova USA, Inc | Implantable medical device without antenna feedthrough |
9108063, | Oct 02 2003 | Medtronic, Inc. | Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device |
20020116042, | |||
20030078633, | |||
20040106963, | |||
20050104577, | |||
20060016452, | |||
20060050539, | |||
20060142822, | |||
20060206166, | |||
20070073357, | |||
20070265675, | |||
20070293914, | |||
20080132961, | |||
20080172109, | |||
20080183236, | |||
20090088816, | |||
20090105785, | |||
20090112291, | |||
20090184857, | |||
20090259273, | |||
20100076254, | |||
20100076534, | |||
20100244859, | |||
20110043394, | |||
20110152959, | |||
20110270269, | |||
20110278948, | |||
20110282416, | |||
20110301667, | |||
20120016447, | |||
20120041512, | |||
20120046712, | |||
20120071950, | |||
20120119698, | |||
20120130448, | |||
20120259381, | |||
20120262108, | |||
20120274270, | |||
20120276854, | |||
20120276856, | |||
20130004925, | |||
20130006330, | |||
20130006331, | |||
20130023958, | |||
20130096651, | |||
20130150925, | |||
20130197608, | |||
20130207863, | |||
20130211479, | |||
20130303942, | |||
20130310894, | |||
20130331909, | |||
20140222112, | |||
20140237806, | |||
20150214604, | |||
DE102010006837, | |||
EP1680182, | |||
EP1904153, | |||
EP2243509, | |||
JP2001108814, | |||
JP2003047179, | |||
JP2011004166, | |||
JP2011114785, | |||
WO56677, | |||
WO66221, | |||
WO203408, | |||
WO2004103465, | |||
WO2008021524, | |||
WO2009051539, | |||
WO2009091267, | |||
WO2010042056, | |||
WO2010042057, | |||
WO2011005607, | |||
WO2011059565, | |||
WO2013141884, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jul 01 2014 | LEE, EDWARD K F | THE ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 046499 | /0900 | |
Apr 22 2015 | Alfred E. Mann Foundation for Scientific Research | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Sep 24 2020 | M2551: Payment of Maintenance Fee, 4th Yr, Small Entity. |
Oct 12 2021 | BIG: Entity status set to Undiscounted (note the period is included in the code). |
Dec 20 2024 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Date | Maintenance Schedule |
Jun 20 2020 | 4 years fee payment window open |
Dec 20 2020 | 6 months grace period start (w surcharge) |
Jun 20 2021 | patent expiry (for year 4) |
Jun 20 2023 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jun 20 2024 | 8 years fee payment window open |
Dec 20 2024 | 6 months grace period start (w surcharge) |
Jun 20 2025 | patent expiry (for year 8) |
Jun 20 2027 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jun 20 2028 | 12 years fee payment window open |
Dec 20 2028 | 6 months grace period start (w surcharge) |
Jun 20 2029 | patent expiry (for year 12) |
Jun 20 2031 | 2 years to revive unintentionally abandoned end. (for year 12) |